rs208294 — P2RX7 His155Tyr

P2RX7 His155Tyr — A Gain-of-Function Variant That Amplifies Neuroinflammation

The P2X7 receptor is an ATP-gated ion channel¹¹ ATP-gated ion channel
The receptor opens when extracellular ATP concentrations are high — a danger signal released by damaged or dying cells — triggering inflammatory cascades expressed abundantly on microglia, the brain's resident immune cells. When activated, P2X7 sets off the NLRP3 inflammasome, a molecular alarm system that releases the inflammatory cytokines IL-1β and IL-18. The His155Tyr variant (rs208294, also notated c.489C>T in older references) causes increased receptor protein expression²² increased receptor protein expression
In vitro studies show that Tyr155 receptors accumulate at higher levels on the cell surface, with both ion channel and pore functions scaling proportionally — more receptors means stronger inflammatory signaling in response to each stress signal. This gain-of-function effect places carriers at a higher neuroinflammatory baseline and contributes to mood vulnerability, pain sensitization, and altered immune responsiveness.

The Mechanism

The His155Tyr substitution occurs in exon 5 of P2RX7³³ exon 5 of P2RX7
His155 encodes histidine in the extracellular domain; the Tyr155 (T allele) variant is the ancestral form that predates the modern reference sequence, within the extracellular domain of the receptor. Western blotting confirmed that the Tyr155 gain-of-function receptors are expressed at higher levels than the His155 form — the functional effect is driven by receptor abundance rather than altered channel kinetics. More P2X7 receptors on microglial and immune cell surfaces means a proportionally stronger ATP-induced response⁴⁴ proportionally stronger ATP-induced response
Enhanced calcium influx, greater potassium efflux, and heightened NLRP3 inflammasome assembly all scale with surface receptor density: more calcium influx, more potassium efflux, and a lower effective threshold for NLRP3 inflammasome activation. The result is that the same tissue stress stimulus produces more IL-1β and IL-18 release. In the brain, this translates to a more reactive microglial state — one that is more prone to neuroinflammation under psychological stress, infection, or metabolic challenge.

The Evidence

Pain sensitivity: In a study of patients with diabetic peripheral neuropathic pain⁵⁵ diabetic peripheral neuropathic pain
Sex-stratified analysis of 156 non-Hispanic Caucasian subjects, the Tyr155 (T) gain-of-function allele was associated with significantly higher pain intensity scores in female patients (p=0.039). Male patients showed no significant association. This sex-specific effect suggests estrogen–P2X7 interactions may amplify the gain-of-function phenotype in women. The Tyr155 variant was also studied in post-mastectomy pain and osteoarthritis cohorts, with mixed but directionally consistent findings.

Mood disorders: A prospective study of 450 patients with major depressive disorder or bipolar disorder followed for a median of 60 months⁶⁶ 450 patients with major depressive disorder or bipolar disorder followed for a median of 60 months
Three independent cohorts with consistent findings found rs208294 significantly elevated familial mood disorder risk (OR 1.35, 95% CI 1.13–1.61, P=0.0013) and predicted more time spent ill, with homozygous T carriers spending 12% more time in mood episodes than C/C carriers. A follow-up structural equation study with 424 patients⁷⁷ 424 patients
Bootstrap-based mediation test, P=0.02 showed that the T allele works through elevated neuroticism — a personality trait capturing emotional reactivity and sensitivity to negative stimuli — which in turn drives a higher proportion of time in depressive and manic episodes. Importantly, not all studies replicate this association: one study of 119 treatment-resistant MDD patients found no association between rs208294 and depression diagnosis or SSRI/ECT remission⁸⁸ no association between rs208294 and depression diagnosis or SSRI/ECT remission
May reflect heterogeneity across severity spectra, and the evidence for mood disorders overall remains moderate rather than strong.

Infection severity: The gain-of-function T allele activates a heightened inflammatory response. During viral infections, this can become harmful. A 2024 study found that homozygous TT genotype was approximately six times more likely in patients with severe COVID-19⁹⁹ homozygous TT genotype was approximately six times more likely in patients with severe COVID-19
Binary logistic regression; TT vs. CT+CC, p=0.022, OR=5.93, 95% CI 1.30–27.14 in an Italian cohort compared to mild cases, consistent with excessive P2X7-driven cytokine release during acute infection.

Bone health: In a cohort of 921 Dutch fracture patients¹⁰¹⁰ 921 Dutch fracture patients
Additive genetic model, p=0.027, carriers of the Tyr155 T allele had reduced femoral neck bone mineral density compared to His155 carriers — an unexpected finding given gain-of-function predictions, but consistent with reports that chronic, low-grade P2X7 overactivation can impair osteoblast function.

Practical Implications

The gain-of-function nature of this variant means that any process that releases extracellular ATP — injury, hypoxia, intense psychological stress, or infection — will produce a stronger inflammatory cascade in T allele carriers. For most daily situations, this difference is unlikely to be noticeable. The clinical relevance is greatest for TT homozygotes and in contexts of elevated inflammatory load: severe infection, chronic pain conditions, and prolonged psychological stress. The mood disorder data is the most consistent finding and is mechanistically coherent: excess microglial IL-1β interferes with serotonin synthesis, disrupts synaptic plasticity, and increases HPA axis reactivity. Anti-inflammatory strategies — specifically those targeting the IL-1β/NLRP3 pathway — are in clinical trials for treatment-resistant depression, and this variant is likely to predict responsiveness to such approaches as the evidence matures.

Interactions

Rs208294 (His155Tyr, gain-of-function) and rs3751143 (Glu496Ala, loss-of-function) have opposite effects on P2X7 activity. Individuals carrying both variants have partially offsetting functional consequences — the net impact on pain, inflammation, and immune function depends on which alleles are present at each locus. A third gain-of-function variant, rs1718119 (Ala348Thr), can compound the effect of rs208294 in individuals who carry both T alleles. Rs7958311 (Arg270His) adds further complexity, with unique effects on channel vs. pore function. Within the mood disorder pathway, P2X7's downstream NLRP3 inflammasome intersects with the NR3C1 glucocorticoid receptor (see rs2963154, rs10515522) — stress hormone signaling and purinergic neuroinflammation converge on microglial activation and synaptic plasticity.